Gemcitabine trials for PDAC - Pancreatic Ductal Adenocarcinoma

All Gemcitabine trials · All PDAC - Pancreatic Ductal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Gemcitabine for PDAC - Pancreatic Ductal Adenocarcinoma

• A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
  NCT07049055 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• BBO-11818 in Adult Subjects With KRAS Mutant Cancer
  NCT06917079 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07491445 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 33 locations

Common questions

How many trials study Gemcitabine for PDAC - Pancreatic Ductal Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.